Form 8-K - Current report:
SEC Accession No. 0001193125-25-172595
Filing Date
2025-08-04
Accepted
2025-08-04 16:05:25
Documents
12
Period of Report
2025-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d16403d8k.htm   iXBRL 8-K 23264
  Complete submission text file 0001193125-25-172595.txt   136945

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250730.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250730_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250730_pre.xml EX-101.PRE 11260
14 EXTRACTED XBRL INSTANCE DOCUMENT d16403d8k_htm.xml XML 3633
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 251180210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)